Vancomycin Dosing for MRSA Infections
For MRSA infections, vancomycin should be dosed at 15-20 mg/kg/dose (based on actual body weight) every 8-12 hours in adults with normal renal function, not to exceed 2 g per dose. 1, 2
Dosing Recommendations by Patient Population
Adults with Normal Renal Function
- Standard dosing: 15-20 mg/kg/dose every 8-12 hours based on actual body weight 1, 2
- Maximum dose: 2 g per dose 1
- Target trough concentrations:
Seriously Ill Patients (sepsis, meningitis, pneumonia, endocarditis)
- Consider loading dose of 25-30 mg/kg (actual body weight) to rapidly achieve therapeutic levels 1, 2
- Standard maintenance dosing should follow loading dose
Children with Serious Infections
- 15 mg/kg/dose every 6 hours 1, 2
- Target trough concentrations of 15-20 μg/mL should be considered for serious infections 1
Monitoring Recommendations
- Obtain trough concentrations immediately before the fourth or fifth dose (at steady state) 2
- Trough concentrations are the most accurate and practical method to guide vancomycin dosing 2
- Monitoring peak concentrations is not recommended 2
- Regular monitoring of renal function is essential 2
Special Considerations
High MIC Strains
- For isolates with vancomycin MIC >2 μg/mL (VISA or VRSA), an alternative to vancomycin should be considered 1
- For isolates with MIC <2 μg/mL, clinical response should determine continued use of vancomycin 1
Treatment Failure
If persistent MRSA bacteremia or vancomycin treatment failure occurs:
- Search for and remove other foci of infection, drainage or surgical debridement 1
- Consider alternative agents:
Administration
- Infuse vancomycin over at least 1 hour to reduce the risk of "red man syndrome" 2
Common Pitfalls and Caveats
Underdosing in obese patients: Weight-based dosing using actual body weight is particularly important in obese patients, who are often underdosed when conventional dosing strategies of 1 g every 12 hours are used 1
Inadequate dosing frequency: A study of critically ill trauma patients found that a regimen of 1 g IV every 12 hours rarely achieved target trough concentrations of 15-20 mg/L, while 1 g IV every 8 hours was more likely to achieve therapeutic levels 3
Failure to adjust for renal function: Vancomycin clearance correlates with creatinine clearance, requiring dose adjustment in renal impairment 4
Nephrotoxicity risk: Higher trough levels (≥15 μg/mL) are associated with increased nephrotoxicity, particularly when combined with other nephrotoxic agents 5, 6. However, this risk must be balanced against the need for adequate treatment of serious MRSA infections.
Failure to recognize treatment failure: For patients not responding to vancomycin despite adequate dosing and source control, alternative therapy should be considered regardless of MIC 1